Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.

[1]  Daniel E. Zak,et al.  A prospective blood RNA signature for tuberculosis disease risk , 2016, The Lancet.

[2]  M. Pai,et al.  Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability? , 2016, Journal of Clinical Microbiology.

[3]  M. Tameris,et al.  Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children , 2015, The Pediatric infectious disease journal.

[4]  P. Hill,et al.  No added value of interferon-γ release to a prediction model for childhood tuberculosis , 2015, European Respiratory Journal.

[5]  Marco Schito,et al.  Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Duarte,et al.  Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study. , 2015, American journal of respiratory and critical care medicine.

[7]  J. Andrews,et al.  The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents. , 2015, American journal of respiratory and critical care medicine.

[8]  L. Myer,et al.  Transmission of tuberculosis in a South African community with a high prevalence of HIV infection. , 2015, The Journal of infectious diseases.

[9]  E. Chiappini,et al.  Interferon-Gamma Release Assay Sensitivity in Children Younger Than 5 Years is Insufficient to Replace the Use of Tuberculin Skin Test in Western Countries , 2014, The Pediatric infectious disease journal.

[10]  J. Kublin,et al.  Tuberculosis Vaccines and Prevention of Infection , 2014, Microbiology and Molecular Reviews.

[11]  T. M. Doherty,et al.  Influence of Age and Nutritional Status on the Performance of the Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube in Young Children Evaluated for Tuberculosis in Southern India , 2014, The Pediatric infectious disease journal.

[12]  S. Esposito,et al.  Performance of interferon-&ggr; Release Assay for the Diagnosis of Active or Latent Tuberculosis in Children in the First 2 Years of Age: A Multicenter Study of the Italian Society of Pediatric Infectious Diseases , 2014, The Pediatric infectious disease journal.

[13]  P. Hermans,et al.  Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts , 2014, BMC Infectious Diseases.

[14]  B. Marshall,et al.  Extremes of Age Are Associated with Indeterminate QuantiFERON-TB Gold Assay Results , 2014, Journal of Clinical Microbiology.

[15]  S. Dorman,et al.  Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. , 2013, American journal of respiratory and critical care medicine.

[16]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[17]  Guidelines on the management of latent tuberculosis infection , 2014 .

[18]  T. Bodmer,et al.  The sensitivity of an interferon-γ release assay in microbiologically confirmed pediatric tuberculosis , 2014, European Journal of Pediatrics.

[19]  R. Lodha,et al.  Role of the QuantiFERON®-TB Gold In-Tube test in the diagnosis of intrathoracic childhood tuberculosis. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[20]  M. Pai,et al.  Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. , 2013, American journal of respiratory and critical care medicine.

[21]  A. Hauri,et al.  How can we achieve better prevention of progression to tuberculosis among contacts? , 2013, European Respiratory Journal.

[22]  S. Lockhart,et al.  Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial , 2013, The Lancet.

[23]  M. Behr,et al.  Repeat IGRA Testing in Canadian Health Workers: Conversions or Unexplained Variability? , 2013, PloS one.

[24]  N. Papadopoulos,et al.  The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection. , 2012, The Journal of pediatrics.

[25]  E. W. Hoskyns,et al.  Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk , 2012, Thorax.

[26]  R. Basu Roy,et al.  Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. , 2012, American journal of respiratory and critical care medicine.

[27]  M. Hoelscher,et al.  QuantiFERON®-TB Gold In-Tube Performance for Diagnosing Active Tuberculosis in Children and Adults in a High Burden Setting , 2012, PloS one.

[28]  D. Plavec,et al.  Serial interferon‐γ release assay in children with latent tuberculosis infection and children with tuberculosis , 2012, Pediatric pulmonology.

[29]  M. Pai,et al.  Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[30]  S. Dorman,et al.  Longitudinal Analysis of QuantiFERON-TB Gold In-Tube in Children with Adult Household Tuberculosis Contact in South Africa: A Prospective Cohort Study , 2011, PloS one.

[31]  M. Pai,et al.  Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[32]  C. Wiysonge,et al.  The Utility of an Interferon Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection and Disease in Children: A Systematic Review and Meta-analysis , 2011, The Pediatric infectious disease journal.

[33]  Shabir A Madhi,et al.  Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. , 2011, The New England journal of medicine.

[34]  M. Pai,et al.  Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[35]  M. Hatherill,et al.  The Tuberculin Skin Test versus QuantiFERON TB Gold® in Predicting Tuberculosis Disease in an Adolescent Cohort Study in South Africa , 2011, PloS one.

[36]  S. Niemann,et al.  Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update. , 2011, American journal of respiratory and critical care medicine.

[37]  N. Papadopoulos,et al.  WHOLE BLOOD INTERFERON-&ggr; RELEASE ASSAY IS A USEFUL TOOL FOR THE DIAGNOSIS OF TUBERCULOSIS INFECTION PARTICULARLY AMONG BACILLE CALMETTE GUèRIN-VACCINATED CHILDREN , 2010, The Pediatric infectious disease journal.

[38]  J. Gomis,et al.  Evaluation of the Prognostic Value of IFN-γ Release Assay and Tuberculin Skin Test in Household Contacts of Infectious Tuberculosis Cases in Senegal , 2010, PloS one.

[39]  A. Crook,et al.  Comparison of interferon-γ release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study , 2009, Archives of Disease in Childhood.

[40]  A. Crook,et al.  Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test , 2009, European Respiratory Journal.

[41]  L. Fabbri,et al.  Performance of Commercial Blood Tests for the Diagnosis of Latent Tuberculosis Infection in Children and Adolescents , 2009, Pediatrics.

[42]  B. Thiers.  Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study , 2007 .

[43]  H. Zar,et al.  Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial , 2006, BMJ : British Medical Journal.

[44]  R. Joshi,et al.  Serial testing of health care workers for tuberculosis using interferon-γ assay , 2006 .

[45]  L. Fabbri,et al.  Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study , 2006, The Lancet.

[46]  R. Joshi,et al.  Serial testing of health care workers for tuberculosis using interferon-gamma assay. , 2006, American journal of respiratory and critical care medicine.

[47]  R. Gie,et al.  The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[48]  C S Berkey,et al.  The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. , 1995, Pediatrics.